The first ever clinical trial for Angiosarcoma is about to begin!

Because angiosarcoma is so rare, clinical trials designed specifically for this disease are typically not thought to be able to recruit enough patients. Angiosarcoma Awareness has been instrumental in allowing doctors to see that there is a population of angiosarcoma patients large enough to design trials. They have initiated the first NCI clinical trial for angiosarcoma.